WebOct 20, 2016 · Perazine is a phenothiazine antipsychotic used in the acute and chronic treatment of psychotic disorders. Generic Name Perazine DrugBank Accession Number DB12710 Background Perazine has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among … WebFluphenazine: Short-acting hydrochloride injection: IM: 1.25: 6: 10: ND: 1 mg short-acting IM injection is equivalent to approximately 2.5 mg oral. ↑ EPS risk. Oral solution: PO: 1 to …
Haloperidol - Wikipedia
WebJan 26, 2024 · Fluphenazine dosing information Usual Adult Dose for Psychosis: Oral: -Initial dose: 2.5 to 10 mg orally in divided doses every 6 to 8 hours -Maintenance dose: 1 to 5 mg/day -Maximum dose: Up to 40 mg/day Oral Comments: -Maintenance doses may be given as single daily doses. WebMar 1, 2024 · Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. The chemical designation is 4- [3- [2- (Trifluoromethyl) phenothiazin-10-yl] propyl]-1-piperazineethanol dihydrochloride. The structural formula is represented below: green city irrigation bc
label - Food and Drug Administration
WebHaloperidol decanoate is provided in the form of 50 or 100 mg/mL oil solution of sesame oil and benzyl alcohol in ampoules or pre-filled syringes. [5] [6] [8] Its elimination half-life after multiple doses is 21 days. [9] [10] The medication is marketed in many countries throughout the world. [2] [11] See also [ edit] WebHaloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations from alcohol withdrawal. [4] [5] [6] It may be used by mouth or injection into a muscle or a vein. [4] Haloperidol typically works within 30 to 60 minutes. [4] WebFeb 1, 2012 · The patient was previously treated with fluphenazine decanoate intermittently for two years with difficulty obtaining the desired therapeutic response. After approximately two months of therapy, the patient presumably at steady state (~14 day half-life) still failed to demonstrate any clinical response. greencitylabhue